Dec. 24 at 1:43 PM
$LCTX
Culley and team are changing the face of medicine — and almost no one on Wall Street is paying attention to what seems like endless promotion. We have acted!!
"That's our opportunity"
Changing the face of Medicine On <
$30M/year, this team is advancing transformational programs across:
• Dry AMD (vision restoration)
• Type-1 Diabetes (functional cure potential)
• Spinal Cord Injury
• Hearing loss
For category-defining indications biotechs have burned hundreds of millions and even Billions chasing.
Capital discipline. World-class science.
No hype cycles. No promotional press. Just methodical progress in some of the hardest diseases in medicine.
This isn’t about tomorrow’s headline — it’s about building irreplaceable assets quietly, before validation forces a re-rating.
When capital discipline meets platform science, value tends to show up all at once, not gradually.
An important and highly valuable company is emerging.
Opening Curtain 26'
🎄 Merry Christmas and GLTA.
